Till Wallrabenstein

433 total citations
4 papers, 36 citations indexed

About

Till Wallrabenstein is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Till Wallrabenstein has authored 4 papers receiving a total of 36 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Till Wallrabenstein's work include Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Advanced Breast Cancer Therapies (1 paper). Till Wallrabenstein is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Advanced Breast Cancer Therapies (1 paper). Till Wallrabenstein collaborates with scholars based in Switzerland, Germany and United States. Till Wallrabenstein's co-authors include Laura C. Cappelli, Heinz Läubli, David König, Jarushka Naidoo, Alfred Zippelius, Martin Buess, Arnoud J. Templeton, Marcus Vetter, Christoph Rochlitz and Anton Oseledchyk and has published in prestigious journals such as PLoS ONE, Journal for ImmunoTherapy of Cancer and Cancer Medicine.

In The Last Decade

Till Wallrabenstein

4 papers receiving 35 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Till Wallrabenstein Switzerland	3	29	14	7	5	3	4	36
Ewa Szutowicz-Zielińska Poland	3	23 0.8×	17 1.2×	9 1.3×	8 1.6×	4 1.3×	5	39
Abhishek Doshi United States	3	19 0.7×	15 1.1×	7 1.0×	4 0.8×	5 1.7×	4	32
Elizabeth Jiménez Aguilar United States	5	29 1.0×	21 1.5×	12 1.7×	7 1.4×	2 0.7×	9	40
Saad Tahir United Kingdom	4	23 0.8×	10 0.7×	5 0.7×	2 0.4×	3 1.0×	4	29
Li‐Hsin Chien Taiwan	4	21 0.7×	10 0.7×	4 0.6×	6 1.2×	4 1.3×	5	34
Corinna Slawinski United Kingdom	2	29 1.0×	9 0.6×	10 1.4×	5 1.0×	7 2.3×	4	45
Kathi Adamson United States	2	19 0.7×	13 0.9×	7 1.0×	10 2.0×	4 1.3×	3	30
Peter Kasan Slovakia	3	28 1.0×	19 1.4×	15 2.1×	3 0.6×	5 1.7×	5	41
Nathalie Prim France	5	19 0.7×	24 1.7×	10 1.4×	3 0.6×	2 0.7×	8	41
Sophia Schuman United States	2	18 0.6×	14 1.0×	21 3.0×	5 1.0×	4 1.3×	5	38

Countries citing papers authored by Till Wallrabenstein

Since Specialization

Citations

This map shows the geographic impact of Till Wallrabenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Wallrabenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Wallrabenstein more than expected).

Fields of papers citing papers by Till Wallrabenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Wallrabenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Wallrabenstein. The network helps show where Till Wallrabenstein may publish in the future.

Co-authorship network of co-authors of Till Wallrabenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Till Wallrabenstein. A scholar is included among the top collaborators of Till Wallrabenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Wallrabenstein. Till Wallrabenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Wallrabenstein, Till, David König, Laura C. Cappelli, et al.. (2024). Corticosteroid-resistant immune-related adverse events: a systematic review. Journal for ImmunoTherapy of Cancer. 12(1). e007409–e007409. 25 indexed citations

2.

Wallrabenstein, Till, et al.. (2023). Real-World Data of Combined Immunochemotherapy in Patients With Nonsquamous Advanced NSCLC. A Single-Center Retrospective Study. JTO Clinical and Research Reports. 4(5). 100509–100509. 2 indexed citations

3.

Wallrabenstein, Till, et al.. (2023). Pegylated liposomal doxorubicin (PLD) in daily practice—A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer. Cancer Medicine. 12(12). 13388–13396. 3 indexed citations

4.

Wallrabenstein, Till, et al.. (2020). Much has changed in the last decade except overall survival: A Swiss single center analysis of treatment and survival in patients with stage IV non-small cell lung cancer. PLoS ONE. 15(5). e0233768–e0233768. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact